Literature DB >> 10826990

The genetics of Parkinson's disease.

H R de Silva1, N L Khan, N W Wood.   

Abstract

The effort to map the entire human genome has led recently to the important milestone publication in late 1999 of the complete sequence of chromosome 22. This has been facilitated by increasingly sophisticated tools for genetic analysis and the ensuing wealth of detailed genetic information. The quest for genetic factors contributing to Parkinson's disease and parkinsonian disorders has revealed a progressively complex picture implicating gene mutations in the rarer, autosomally inherited forms of Parkinson's disease and the interplay of genetic and/or environmental factors in the common sporadic forms of the disorder. These findings not only reiterate the complex genetic heterogeneity of Parkinson's disease but could also point towards common pathogenic mechanisms in Parkinson's disease and related neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10826990     DOI: 10.1016/s0959-437x(00)00082-4

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  16 in total

1.  Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.

Authors:  M Periquet; C Lücking; J Vaughan; V Bonifati; A Dürr; G De Michele; M Horstink; M Farrer; S N Illarioshkin; P Pollak; M Borg; C Brefel-Courbon; P Denefle; G Meco; T Gasser; M M Breteler; N Wood; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  2001-02-14       Impact factor: 11.025

2.  The septin CDCrel-1 is dispensable for normal development and neurotransmitter release.

Authors:  Xiao-Rong Peng; Zhengping Jia; Yu Zhang; Jerry Ware; William S Trimble
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

Authors:  Hui-Ming Gao; Jau-Shyong Hong; Wanqin Zhang; Bin Liu
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 4.  Psychogenomics: opportunities for understanding addiction.

Authors:  E J Nestler
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

5.  Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

Authors:  Eliseu Felippe dos Santos; Estela Natacha Brandt Busanello; Anelise Miglioranza; Angela Zanatta; Alethea Gatto Barchak; Carmen Regla Vargas; Jonas Saute; Charles Rosa; Maria Júlia Carrion; Daiane Camargo; André Dalbem; Jaderson Costa da Costa; Sandro René Pinto de Sousa Miguel; Carlos Roberto de Mello Rieder; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

Review 6.  Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

Authors:  M Reale; N H Greig; M A Kamal
Journal:  Mini Rev Med Chem       Date:  2009-09       Impact factor: 3.862

7.  Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease.

Authors:  Yih-Ru Wu; Cheng-Kuang Wang; Chiung-Mei Chen; Yuying Hsu; Sih-Jing Lin; Yi-Ying Lin; Hon-Chung Fung; Kuo-Hsuan Chang; Guey-Jen Lee-Chen
Journal:  Hum Genet       Date:  2003-11-06       Impact factor: 4.132

Review 8.  Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.

Authors:  Lisa Fellner; Kurt A Jellinger; Gregor K Wenning; Nadia Stefanova
Journal:  Acta Neuropathol       Date:  2011-05-12       Impact factor: 17.088

9.  Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.

Authors:  X G Xia; T Harding; M Weller; A Bieneman; J B Uney; J B Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 10.  Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.

Authors:  Bin Liu; Hui-Ming Gao; Jau-Shyong Hong
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.